Efficacy and safety of adjunctive topiramate for schizophrenia: a meta‐analysis of randomized controlled trials
Year: 2016
Type: review
Study designs: Systematic Review, Meta-Analysis
Source: Acta Psychiatrica Scandinavica
DOI: 10.1111/acps.12631
Authors: W. Zheng, Y.‐T. Xiang, Y.‐Q. Xiang, X.‐B. Li, G. S. Ungvari, H. F. K. Chiu, C. U. Correll
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Keywords: topiramate, schizophrenia, adjunctive therapy, antipsychotic drugs, clozapine, symptom relief, weight loss, body mass index, triglycerides, insulin, tolerability, adverse effects, disease duration, Asian populations, Chinese patients, subgroup analysis, publication bias, heterogeneity, risk of bias, number needed to harm
Open Access status: closed
Funders: Bristol-Myers Squibb, Pfizer, H. Lundbeck A/S
OpenAlex ID: W2515404667
